Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “OSTEOPOROSIS, POSTMENOPAUSAL”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00043719
What this trial is testing

Nitroglycerin Ointment for Preventing Bone Loss in Postmenopausal Women

Who this might be right for
OsteoporosisOsteopenia
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) 200
Early research (Phase 1)Study completedNCT01293045
What this trial is testing

Biological Bone Markers and Hydrolyzed Collagen Supplement in Menopausal Healthy Women

Who this might be right for
Osteoporosis
Nealth Sarl 44
Not applicableStudy completedNCT03959995
What this trial is testing

Effects of Physical Exercise on Postmenopausal Risk Factors in Women With Osteopenia

Who this might be right for
Osteopenia, Osteoporosis
University of Erlangen-Nürnberg Medical School 27
Testing effectiveness (Phase 2)Study completedNCT00996801
What this trial is testing

MK-5442 in the Treatment of Osteoporosis in Postmenopausal Women Previously Treated With an Oral Bisphosphonate (MK-5442-012)

Who this might be right for
OsteoporosisPostmenopausal Osteoporosis
Merck Sharp & Dohme LLC 526
Post-approval studies (Phase 4)Ended earlyNCT00577395
What this trial is testing

Bone Microarchitecture in Osteopenic Postmenopausal Women

Who this might be right for
Osteoporosis
Warner Chilcott 13
Early research (Phase 1)Study completedNCT00641771
What this trial is testing

4-Week Study to Assess the Effect of Alendronate and Vitamin D3 Once Weekly on Fractional Calcium Absorption in Postmenopausal Osteoporotic Women (0217A-230)

Who this might be right for
Osteoporosis
Organon and Co 56
Not applicableStudy completedNCT00696644
What this trial is testing

Teriparatide in Severe Osteoporosis

Who this might be right for
Osteoporosis, PostmenopausalOsteoporosis
Eli Lilly and Company 794
Large-scale testing (Phase 3)Study completedNCT00310531
What this trial is testing

3-year Study of Menostar Versus Evista to Prevent Osteoporosis in Post-menopausal Women

Who this might be right for
Osteopenia
Bayer 500
Large-scale testing (Phase 3)Study completedNCT00481169
What this trial is testing

Study Evaluating TSE-424/Placebo/Raloxifene in Preventing Osteoporosis in Postmenopausal Women

Who this might be right for
Osteoporosis
Wyeth is now a wholly owned subsidiary of Pfizer 1,742
Large-scale testing (Phase 3)Study completedNCT05345691
What this trial is testing

Comparison of Efficacy, Pharmacodynamics, Safety, and Immunogenicity Between Bmab 1000 and Prolia® in Postmenopausal Women With Osteoporosis

Who this might be right for
Postmenopausal Women With Osteoporosis
Biocon Biologics UK Ltd 479
Not applicableStudy completedNCT01652690
What this trial is testing

Prospective Observational Study to Describe Characteristics and Management of Patients Treated With Denosumab (Prolia®) in Routine Clinical Practice

Who this might be right for
Osteoporosis, Postmenopausal
Amgen 600
Post-approval studies (Phase 4)Study completedNCT00549965
What this trial is testing

Satisfaction and Compliance of Risedronate in PMO

Who this might be right for
Osteoporosis, Postmenopausal
Sanofi 202
Large-scale testing (Phase 3)Study completedNCT00890981
What this trial is testing

A High-resolution Peripheral Quantitative Computed Tomography Study in Postmenopausal Women Previously Treated With Denosumab

Who this might be right for
Low Bone MassLow Bone Mineral DensityOsteoporosis+1 more
Amgen 79
Large-scale testing (Phase 3)Study completedNCT05215977
What this trial is testing

Efficacy and Safety of MW031 in PMO Subjects

Who this might be right for
Osteoporosis, Postmenopausal
Mabwell (Shanghai) Bioscience Co., Ltd. 448
Large-scale testing (Phase 3)Study completedNCT01463436
What this trial is testing

The Effect of Soy Isoflavone Supplementation on Endothelial Function

Who this might be right for
Cardiovascular DiseaseOsteoporosis
Trisakti University 200
Not applicableStudy completedNCT01386281
What this trial is testing

Julina Post-marketing Surveillance for Climacteric Symptoms in Japan

Who this might be right for
Osteoporosis, Postmenopausal
Bayer 506
Large-scale testing (Phase 3)Study completedNCT00345644
What this trial is testing

Risedronate in Osteopenic Postmenopausal Women

Who this might be right for
Osteoporosis
Sanofi 156
Post-approval studies (Phase 4)Study completedNCT00491920
What this trial is testing

High Dosage Vitamin D and Osteoporosis

Who this might be right for
OsteoporosisOsteopenia
University Hospital of North Norway 297
Large-scale testing (Phase 3)Study completedNCT00404820
What this trial is testing

Safety/Efficacy of Zoledronic Acid and Alendronate on Bone Metabolism in Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis
Novartis 604
Testing effectiveness (Phase 2)Study completedNCT00542425
What this trial is testing

Phase 2 Dose-finding Study to Evaluate the Effects of BA058 in the Treatment of Postmenopausal Women With Osteoporosis

Who this might be right for
Osteoporosis
Radius Health, Inc. 222
Next Page